Nonprescription drugs (OTC) are defined as drugs that are safe and effective for use by the general public without advice from a health professional.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Non-prescription Drugs industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Brand Drugs
Generic Drug
Market Segment by Product Application
Hospital
Clinic
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Shire
Boehringer Ingelheim
Takeda
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Non-prescription Drugs consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Non-prescription Drugs market by identifying its various subsegments.
3.Focuses on the key global Non-prescription Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Non-prescription Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Non-prescription Drugs submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Non-prescription Drugs Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Non-prescription Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Non-prescription Drugs Segment by Type
2.1.1 Brand Drugs
2.1.2 Generic Drug
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Other
2.3 Global Non-prescription Drugs Market Comparison by Regions (2017-2027)
2.3.1 Global Non-prescription Drugs Market Size (2017-2027)
2.3.2 North America Non-prescription Drugs Status and Prospect (2017-2027)
2.3.3 Europe Non-prescription Drugs Status and Prospect (2017-2027)
2.3.4 China Non-prescription Drugs Status and Prospect (2017-2027)
2.3.5 Japan Non-prescription Drugs Status and Prospect (2017-2027)
2.3.6 Southeast Asia Non-prescription Drugs Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Non-prescription Drugs Industry Impact
2.5.1 Non-prescription Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Non-prescription Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Non-prescription Drugs Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Non-prescription Drugs Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Non-prescription Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Non-prescription Drugs Manufacturer Market Share
3.5 Top 10 Non-prescription Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Non-prescription Drugs Market
3.7 Key Manufacturers Non-prescription Drugs Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Non-prescription Drugs Industry Key Manufacturers
4.1 Pfizer
4.1.1 Compan Detail
4.1.2 Pfizer Non-prescription Drugs Product Introduction, Application and Specification
4.1.3 Pfizer 167 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Pfizer News
4.2 Roche
4.2.1 Compan Detail
4.2.2 Roche Non-prescription Drugs Product Introduction, Application and Specification
4.2.3 Roche Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Pfizer News
4.3 Sanofi
4.3.1 Compan Detail
4.3.2 Sanofi Non-prescription Drugs Product Introduction, Application and Specification
4.3.3 Sanofi Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Sanofi News
4.4 Johnson & Johnson
4.4.1 Compan Detail
4.4.2 Johnson & Johnson Non-prescription Drugs Product Introduction, Application and Specification
4.4.3 Johnson & Johnson Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Johnson & Johnson News
4.5 Merck & Co. (MSD)
4.5.1 Compan Detail
4.5.2 Johnson & Johnson Non-prescription Drugs Product Introduction, Application and Specification
4.5.3 Merck & Co. (MSD) Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Merck & Co. (MSD) News
4.6 Novartis
4.6.1 Compan Detail
4.6.2 Novartis Non-prescription Drugs Product Introduction, Application and Specification
4.6.3 Novartis Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Novartis News
4.7 AbbVie
4.7.1 Compan Detail
4.7.2 AbbVie Non-prescription Drugs Product Introduction, Application and Specification
4.7.3 AbbVie Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Gilead Sciences
4.8.1 Compan Detail
4.8.2 Gilead Sciences Non-prescription Drugs Product Introduction, Application and Specification
4.8.3 Gilead Sciences Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Gilead Sciences News
4.9 GlaxoSmithKline (GSK)
4.9.1 Compan Detail
4.9.2 GlaxoSmithKline (GSK) Non-prescription Drugs Product Introduction, Application and Specification
4.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 GlaxoSmithKline (GSK) News
4.10 Amgen
4.10.1 Compan Detail
4.10.2 Amgen Non-prescription Drugs Product Introduction, Application and Specification
4.10.3 Amgen Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Amgen News
4.11 AstraZeneca
4.11.1 Compan Detail
4.11.2 AstraZeneca Non-prescription Drugs Product Introduction, Application and Specification
4.11.3 AstraZeneca Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 AstraZeneca News
4.12 Bristol-Myers Squibb
4.12.1 Compan Detail
4.12.2 Bristol-Myers Squibb Non-prescription Drugs Product Introduction, Application and Specification
4.12.3 Bristol-Myers Squibb Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Bristol-Myers Squibb News
4.13 Eli Lilly
4.13.1 Company Details
4.13.2 Eli Lilly Non-prescription Drugs Product Introduction, Application and Specification
4.13.3 Eli Lilly Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Eli Lilly News
4.14 Teva
4.14.1 Compan Detail
4.14.2 Teva Non-prescription Drugs Product Introduction, Application and Specification
4.14.3 Teva Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Teva News
4.15 Bayer
4.15.1 Compan Detail
4.15.2 Bayer Non-prescription Drugs Product Introduction, Application and Specification
4.15.3 Bayer Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Bayer News
4.16 Novo Nordisk
4.16.1 Compan Detail
4.16.2 Novo Nordisk Non-prescription Drugs Product Introduction, Application and Specification
4.16.3 Novo Nordisk Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Novo Nordisk News
4.17 Allergan
4.17.1 Compan Detail
4.17.2 Allergan Non-prescription Drugs Product Introduction, Application and Specification
4.17.3 Allergan Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 Allergan News
4.18 Shire
4.18.1 Compan Detail
4.18.2 Shire Non-prescription Drugs Product Introduction, Application and Specification
4.18.3 Shire Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 Shire News
4.19 Boehringer Ingelheim
4.19.1 Compan Detail
4.19.2 Boehringer Ingelheim Non-prescription Drugs Product Introduction, Application and Specification
4.19.3 Boehringer Ingelheim Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.19.4 Main Business Overview
4.19.5 Boehringer Ingelheim News
4.20 Takeda
4.20.1 Compan Detail
4.20.2 Takeda Non-prescription Drugs Product Introduction, Application and Specification
4.20.3 Takeda Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.20.4 Main Business Overview
4.20.5 Takeda News
5 Global Non-prescription Drugs Market Segment by Big Type
5.1 Global Non-prescription Drugs Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Non-prescription Drugs Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Non-prescription Drugs Revenue and Market Share by Big Type (2017-2022)
5.2 Brand Drugs Sales Growth Rate and Price
5.2.1 Global Brand Drugs Sales Growth Rate (2017-2022)
5.2.2 Global Brand Drugs Price (2017-2022)
5.3 Generic Drug Sales Growth Rate and Price
5.3.1 Global Generic Drug Sales Growth Rate (2017-2022)
5.3.2 Global Generic Drug Price (2017-2022)
6 Global Non-prescription Drugs Market Segment by Big Application
6.1 Global Non-prescription Drugs Sales Market Share by Big Application (2017-2022)
6.2 Hospital Sales Growth Rate (2017-2022)
6.3 Clinic Sales Growth Rate (2017-2022)
6.4 Other Sales Growth Rate (2017-2022)
7 Global Non-prescription Drugs Forecast
7.1 Global Non-prescription Drugs Revenue, Sales and Growth Rate (2022-2027)
7.2 Non-prescription Drugs Market Forecast by Regions (2022-2027)
7.2.1 North America Non-prescription Drugs Market Forecast (2022-2027)
7.2.2 Europe Non-prescription Drugs Market Forecast (2022-2027)
7.2.3 China Non-prescription Drugs Market Forecast (2022-2027)
7.2.4 Japan Non-prescription Drugs Market Forecast (2022-2027)
7.2.5 Southeast Asia Non-prescription Drugs Market Forecast (2022-2027)
7.2.6 Other Regions Non-prescription Drugs Market Forecast (2022-2027)
7.3 Non-prescription Drugs Market Forecast by Type (2022-2027)
7.3.1 Global Non-prescription Drugs Sales Forecast by Type (2022-2027)
7.3.2 Global Non-prescription Drugs Market Share Forecast by Type (2022-2027)
7.4 Non-prescription Drugs Market Forecast by Application (2022-2027)
7.4.1 Global Non-prescription Drugs Sales Forecast by Application (2022-2027)
7.4.2 Global Non-prescription Drugs Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Non-prescription Drugs Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Non-prescription Drugs Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Non-prescription Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Non-prescription Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Non-prescription Drugs Market Size by Big Type
Figure Global Market Share of Non-prescription Drugs by Big Type in 2021
Figure Brand Drugs Picture (2017-2022)
Global Non-prescription Drugs Market Size by Big Application
Table Global Non-prescription Drugs Market Size by Application
Figure Global Non-prescription Drugs Market Share by Big Application in 2021
Figure Hospital Picture
Figure Clinic Picture
Figure Other Picture
Table Global Non-prescription Drugs Comparison by Regions (M USD) (2017-2027?
Figure Global Non-prescription Drugs Market Size (Million US$) (2017-2027)
Figure North America Non-prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Non-prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure China Non-prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Non-prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Non-prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Non-prescription Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Non-prescription Drugs Sales by Manufacturer (2017-2022)
Figure Global Non-prescription Drugs Sales Market Share by Manufacturer in 2021
Table Global Non-prescription Drugs Revenue by Manufacturer (2017-2022)
Figure Global Non-prescription Drugs Revenue Market Share by Manufacturer in 2021
Table Global Non-prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Non-prescription Drugs Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Non-prescription Drugs Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Non-prescription Drugs Market
Table Key Manufacturers Non-prescription Drugs Product Type
Table Mergers & Acquisitions Planning
Table Pfizer Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Pfizer
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Roche Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Roche
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Roche Recent Development
Table Sanofi Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Sanofi
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi Main Business
Table Sanofi Recent Development
Table Johnson & Johnson Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Johnson & Johnson
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Merck & Co. (MSD) Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Merck & Co. (MSD)
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck & Co. (MSD) Main Business
Table Merck & Co. (MSD) Recent Development
Table Novartis Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Novartis
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table AbbVie Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of AbbVie
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AbbVie Main Business
Table AbbVie Recent Development
Table Gilead Sciences Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Gilead Sciences
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Gilead Sciences Main Business
Table Gilead Sciences Recent Development
Table GlaxoSmithKline (GSK) Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of GlaxoSmithKline (GSK)
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GlaxoSmithKline (GSK) Main Business
Table GlaxoSmithKline (GSK) Recent Development
Table Amgen Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Amgen
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Amgen Main Business
Table Amgen Recent Development
Table AstraZeneca Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of AstraZeneca
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Bristol-Myers Squibb Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Bristol-Myers Squibb
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Eli Lilly
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Teva Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Teva
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Main Business
Table Teva Recent Development
Table Novo Nordisk Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Novo Nordisk
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novo Nordisk Main Business
Table Novo Nordisk Recent Development
Table Allergan Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Allergan
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Allergan Main Business
Table Allergan Recent Development
Table Shire Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Shire
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Shire Main Business
Table Shire Recent Development
Table Boehringer Ingelheim Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Boehringer Ingelheim
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Boehringer Ingelheim Main Business
Table Boehringer Ingelheim Recent Development
Table Takeda Company Profile
Table Non-prescription Drugs Product Introduction, Application and Specification of Takeda
Table Non-prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Takeda Main Business
Table Takeda Recent Development
Figure Global Non-prescription Drugs Sales and Growth Rate (2017-2022)
Figure Global Non-prescription Drugs Revenue and Growth Rate (2017-2022)
Table Global Non-prescription Drugs Sales by Regions (2017-2022)
Figure Global Non-prescription Drugs Sales Market Share by Regions in 2021
Table Global Non-prescription Drugs Revenue by Regions (2017-2022)
Figure Global Non-prescription Drugs Revenue Market Share by Regions in 2021
Figure North America Non-prescription Drugs Sales and Growth Rate (2017-2022)
Figure Europe Non-prescription Drugs Sales and Growth Rate (2017-2022)
Figure China Non-prescription Drugs Sales and Growth Rate (2017-2022)
Figure Japan Non-prescription Drugs Sales and Growth Rate (2017-2022)
Figure Southeast Asia Non-prescription Drugs Sales and Growth Rate (2017-2022)
Figure Other Regions Non-prescription Drugs Sales and Growth Rate (2017-2022)
Table Global Non-prescription Drugs Sales by Big Type (2017-2022)
Table Global Non-prescription Drugs Sales Market Share by Big Type (2017-2022)
Figure Global Non-prescription Drugs Sales Market Share by Big Type in 2019
Table Global Non-prescription Drugs Revenue by Big Type (2017-2022)
Table Global Non-prescription Drugs Revenue Market Share by Big Type (2017-2022)
Table Global Non-prescription Drugs Revenue Market Share by Big Type in 2019
Figure Global Brand Drugs Sales Growth Rate (2017-2022)
Figure Global Brand Drugs Price (2017-2022)
Figure Global Generic Drug Sales Growth Rate (2017-2022)
Table Global Non-prescription Drugs Sales by Big Application (2017-2022)
Table Global Non-prescription Drugs Sales Market Share by Big Application (2017-2022)
Figure Global Non-prescription Drugs Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Clinic Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Non-prescription Drugs Sales and Growth Rate (2022-2027)
Figure Global Non-prescription Drugs Revenue and Growth Rate (2022-2027)
Table Global Non-prescription Drugs Sales Forecast by Regions (2022-2027)
Table Global Non-prescription Drugs Market Share Forecast by Regions (2022-2027)
Figure North America Sales Non-prescription Drugs Market Forecast (2022-2027)
Figure Europe Sales Non-prescription Drugs Market Forecast (2022-2027)
Figure China Sales Non-prescription Drugs Market Forecast (2022-2027)
Figure Japan Sales Non-prescription Drugs Market Forecast (2022-2027)
Figure Southeast Asia Sales Non-prescription Drugs Market Forecast (2022-2027)
Figure Other Regions Sales Non-prescription Drugs Market Forecast (2022-2027)
Table Global Non-prescription Drugs Sales Forecast by Type (2022-2027)
Table Global Non-prescription Drugs Market Share Forecast by Type (2022-2027)
Table Global Non-prescription Drugs Sales Forecast by Application (2022-2027)
Table Global Non-prescription Drugs Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-prescription Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Non-prescription Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Non-prescription Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Non-prescription Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Non-prescription Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Non-prescription Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Non-prescription Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Non-prescription Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Non-prescription Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Shire
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)